Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

DATA PRESENTED AT ACC.26 DEMONSTRATE A HIGH PREVALENCE OF CLINICALLY ACTIONABLE ARRHYTHMIAS ACROSS CKM PATIENT POPULATIONS USING THE ZIO  AMBULATORY ECG PORTFOLIO. 1,2 CHIEF MEDICAL OFFICER MINTU TURAKHIA, MD, MS, DELIVERED THE 57TH ANNUAL LOUIS F.

DATA PRESENTED AT ACC.26 FURTHER DEMONSTRATE THE BENEFITS OF IRHYTHM'S ZIO AMBULATORY ECG PORTFOLIO ACROSS MULTIPLE PATIENT POPULATIONS AS COMPANY LAUNCHES NEW DIGITAL EDUCATION PLATFORM

SAN FRANCISCO, MARCH 12, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, IS PLEASED TO ANNOUNCE THE APPOINTMENT OF JASON PATTEN TO ITS BOARD OF DIRECTORS, EFFECTIVE MARCH 12, 2026. MR. PATTEN BRINGS DECADES OF STRATEGIC LEADERSHIP IN HEALTHCARE, REINFORCING IRHYTHM'S COMMITMENT TO INNOVATION, OPERATIONAL EXCELLENCE, AND LONG-TERM GROWTH.

IRHYTHM HOLDINGS APPOINTS JASON PATTEN TO ITS BOARD OF DIRECTORS

SAN FRANCISCO, FEB. 19, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ: IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY REPORTED FINANCIAL RESULTS FOR THE THREE MONTHS AND FULL YEAR ENDED DECEMBER 31, 2025. FOURTH QUARTER 2025 FINANCIAL HIGHLIGHTS REVENUE OF $208.9 MILLION, A 27.1% INCREASE COMPARED TO FOURTH QUARTER 2024 GROSS MARGIN OF 70.9%, A 90-BASIS POINT INCREASE COMPARED TO FOURTH QUARTER 2024 NET INCOME OF $5.6 MILLION, A $6.9MILLION IMPROVEMENT COMPARED TO FOURTH QUARTER 2024 AND THE FIRST QUARTER OF POSITIVE GAAP NET INCOME IN COMPANY HISTORY ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN OF $34.3 MILLION AND 16.4%, RESPECTIVELY, A $15.0MILLION AND 470-BASIS POINT IMPROVEMENT, RESPECTIVELY, COMPARED TO FOURTH QUARTER 2024 UNRESTRICTED CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $583.8 MILLION AT DECEMBER 31, 2025, A $18.6 MILLION INCREASE FROM SEPTEMBER 30, 2025 FULL YEAR 2025 FINANCIAL HIGHLIGHTS REVENUE OF $747.1 MILLION, A 26.2% INCREASE COMPARED TO FULL YEAR 2024 GROSS MARGIN OF 70.6%, A 170-BASIS POINT INCREASE COMPARED TO FULL YEAR 2024 NET LOSS OF $44.6 MILLION, A $68.7 MILLION IMPROVEMENT COMPARED TO FULL YEAR 2024 ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN OF $68.9 MILLION AND 9.2%, RESPECTIVELY, A $76.7 MILLION AND 1,050-BASIS POINT IMPROVEMENT, RESPECTIVELY COMPARED TO FULL YEAR 2024 FREE CASH FLOW OF $34.5 MILLION, THE FIRST YEAR OF POSITIVE FREE CASH FLOW IN COMPANY HISTORY RECENT OPERATIONAL HIGHLIGHTS RECORD QUARTERLY REVENUE AND FIFTH CONSECUTIVE QUARTERLY REVENUE ABOVE 20% YEAR-OVER-YEAR GROWTH, DRIVEN BY VOLUME ACROSS OUR US CORE BUSINESS, INNOVATIVE HEALTH CHANNELS, AND INTERNATIONAL MARKETS UPCOMING DATA PRESENTATIONS AT THE AMERICAN COLLEGE OF CARDIOLOGY'S ANNUAL SCIENTIFIC SESSION & EXPO IN NEW ORLEANS, LOUISIANA, FROM MARCH 28  30, 2026 THE FOURTH QUARTER CAPPED A TRANSFORMATIONAL YEAR FOR IRHYTHM, SAID QUENTIN BLACKFORD, PRESIDENT AND C

IRHYTHM HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS

SAN FRANCISCO, FEB. 05, 2026 (GLOBE NEWSWIRE) -- IRHYTHM HOLDINGS, INC. (NASDAQ:IRTC), A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREVENT, AND PREDICT DISEASE, TODAY ANNOUNCED THAT IT WILL RELEASE FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR 2025 AFTER THE CLOSE OF TRADING ON THURSDAY, FEBRUARY 19, 2026. THE COMPANY'S MANAGEMENT TEAM WILL HOST A CORRESPONDING CONFERENCE CALL BEGINNING AT 1:30 P.M. PT / 4:30 P.M. ET.

IRHYTHM HOLDINGS TO REPORT FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS ON FEBRUARY 19, 2026

SHAREHOLDERS SHOULD CONTACT THE FIRM IMMEDIATELY AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS.  NEW YORK, JAN. 29, 2026 /PRNEWSWIRE/ -- HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS.

HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

NEW YORK, JAN. 28, 2026 (GLOBE NEWSWIRE) -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS.

KUEHN LAW ENCOURAGES INVESTORS OF IRHYTHM TECHNOLOGIES, INC. TO CONTACT LAW FIRM

NEW YORK, JAN. 21, 2026 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT IRHYTHM CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE THAT THE ZIO AT MONITOR WAS A REAL-TIME MONITOR INTENDED FOR HIGH-RISK PATIENTS.

NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. IF YOU CURRENTLY OWN IRHYTHM STOCK AND ARE A LONG-TERM SHAREHOLDER, YOU MAY BE ABLE TO SEEK CORPORATE GOVERNANCE REFORMS, THE RETURN OF FUNDS BACK TO THE COMPANY, A COURT-APPROVED FINANCIAL INCENTIVE AWARD, OR OTHER RELIEF AND BENEFITS. PLEASE CLICK HERE TO LEARN MORE ABOUT.

NEW YORK, JAN. 15, 2026 (GLOBE NEWSWIRE) -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS.

SAN FRANCISCO, JAN. 12, 2026 (GLOBE NEWSWIRE) -- IRHYTHM TECHNOLOGIES, INC. (NASDAQ:IRTC) A LEADING DIGITAL HEALTH CARE COMPANY FOCUSED ON CREATING TRUSTED SOLUTIONS THAT DETECT, PREDICT, AND PREVENT DISEASE, TODAY ANNOUNCED PRELIMINARY FOURTH QUARTER OPERATIONAL HIGHLIGHTS AND A BUSINESS UPDATE AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE.

IRHYTHM TECHNOLOGIES, INC. SHARES PRELIMINARY FOURTH QUARTER 2025 HIGHLIGHTS AND BUSINESS UPDATE AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

NEW YORK, JAN. 7, 2026 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF IRHYTHM TECHNOLOGIES, INC. (NASDAQ: IRTC) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT IRHYTHM CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE THAT THE ZIO AT MONITOR WAS A REAL-TIME MONITOR INTENDED FOR HIGH-RISK PATIENTS.

iRhythm Technologies, Inc.

IRTC

Price

Financial Reports

No items found.

Press Releases

iRhythm Technologies, Inc.

IRTC.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financial Reports

No items found.

Press Releases

IRTC